Friends Research Institute; and Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, Baltimore, Maryland.
Send correspondence and reprint requests to Robert P. Schwartz, MD, Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201-5633. E-mail: [email protected].
Received 8 April, 2016
Accepted 21 April, 2016
Source of funding: This work was supported through National Institute on Drug Abuse (NIDA) Grant Nos. 2R01DA15842 and 2U01DA013636. NIDA or the National Institutes of Health hand no role in the preparation, review, or approval of this manuscript.
Conflict of interest: The author performed a 1-time consultation for Reckitt Benckiser on behalf of his employer.
